Janssen's Invokana Now Approved to Reduce Risk of Major CV Events

Press/Media: Press / Media

PeriodOct 31 2018

Media coverage

2

Media coverage

  • TitleJanssen's Invokana Now Approved to Reduce Risk of Major CV Events
    Media name/outletResearch & Development
    CountryUnited States
    Date10/31/18
    PersonsRalph A Defronzo
  • TitleJanssen's Invokana Now Approved to Reduce Risk of Major CV Events
    Media name/outletPharmaceuticalProcessing
    CountryUnited States
    Date10/31/18
    PersonsRalph A Defronzo